FDANonrulemakingFDA-2025-N-0873

Who commented on this docket

Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments

1 organizations filed 1 public comment on Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 351d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 351d ago

Abstract

Open

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.